Steveoh,
I thought that because NNZ-2591 is designated for rare disease, it doesn't need a PRV as FDA assess within an accelerated (6month) timeframe. I could be wrong though???
Acadia, page-9
-
- There are more pages in this discussion • 619 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.82 |
Change
-0.280(1.39%) |
Mkt cap ! $2.569B | |||
| Open | High | Low | Value | Volume |
| $20.17 | $20.17 | $19.81 | $402.1K | 20.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 59 | $19.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.83 | 136 | 4 |
View Market Depth
| Last trade - 10.25am 03/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |